ABBV.NYSEAbbvie INC

Form 4: AbbVie Director Susan Quaggin Reports Stock Acquisition

Sentiment:

Statement of Changes in Beneficial Ownership


AbbVie Inc. director Susan E. Quaggin reported the acquisition of 1,118 restricted stock units under the company's incentive stock program.

Summary

  • Susan E. Quaggin, a Director at AbbVie Inc., acquired 1,118 restricted stock units (RSUs) on May 8, 2026.
  • These RSUs were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program.
  • The RSUs will be settled on a one-to-one basis in shares of AbbVie common stock.
  • Settlement will occur upon the director's separation from service, death, or a change in control.
  • Following this transaction, Quaggin beneficially owns 3,643 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard award of restricted stock units to a director rather than an open market purchase or sale.

Positives

  • Director acquisition of company stock can signal confidence in the company's future prospects.
  • The award of restricted stock units aligns management and director interests with shareholders.

Risks

  • The value of the restricted stock units is subject to market fluctuations and the company's stock performance.
  • Potential for a change in control event, which could trigger settlement but may also indicate broader strategic shifts.

Future Outlook

The restricted stock units are subject to vesting conditions tied to separation from service, death, or change in control, indicating future potential share issuance.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by an AbbVie director, are common in the pharmaceutical and biotechnology sectors as a means of executive compensation and aligning interests.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Incentive Stock ProgramAward of restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.05/08/2026Reinforces alignment of director compensation with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The acquisition of RSUs by a director can be viewed positively as it aligns director incentives with long-term company performance.
  • Management/Directors: The RSUs represent a form of compensation and potential future equity ownership.

Next Steps

  • Settlement of restricted stock units upon the occurrence of specific events (separation from service, death, or change in control).

Key Dates

DateDescription
05/08/2026Transaction Date for acquisition of restricted stock units.
05/12/2026Date of signature for the filing.

Keywords

AbbVie Inc., ABBV, Form 4, Insider Trading, Restricted Stock Units, Director, Stock Acquisition, Incentive Stock Program, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.